JP2012514006A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012514006A5 JP2012514006A5 JP2011543717A JP2011543717A JP2012514006A5 JP 2012514006 A5 JP2012514006 A5 JP 2012514006A5 JP 2011543717 A JP2011543717 A JP 2011543717A JP 2011543717 A JP2011543717 A JP 2011543717A JP 2012514006 A5 JP2012514006 A5 JP 2012514006A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- disorder
- hydrogen
- carbons
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14103008P | 2008-12-29 | 2008-12-29 | |
| US61/141,030 | 2008-12-29 | ||
| PCT/US2009/069716 WO2010078348A1 (en) | 2008-12-29 | 2009-12-29 | 3.1.0 bicyclic glyt1 inhibitors and methods of making and using same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012514006A JP2012514006A (ja) | 2012-06-21 |
| JP2012514006A5 true JP2012514006A5 (enExample) | 2013-01-31 |
Family
ID=42310195
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011543717A Pending JP2012514006A (ja) | 2008-12-29 | 2009-12-29 | ３．１．０二環式ＧｌｙＴ１阻害剤ならびにその作製および使用の方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8497289B2 (enExample) |
| EP (1) | EP2381941A4 (enExample) |
| JP (1) | JP2012514006A (enExample) |
| KR (1) | KR20110117087A (enExample) |
| CN (1) | CN102271677A (enExample) |
| AU (1) | AU2009335120A1 (enExample) |
| BR (1) | BRPI0923878A2 (enExample) |
| CA (1) | CA2747602A1 (enExample) |
| IL (1) | IL213541A0 (enExample) |
| MX (1) | MX2011006845A (enExample) |
| RU (1) | RU2011124709A (enExample) |
| WO (1) | WO2010078348A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9012489B2 (en) * | 2011-08-03 | 2015-04-21 | Boehringer Ingelheim International Gmbh | Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament |
| BR112016025910A8 (pt) * | 2014-05-06 | 2021-07-13 | Univ Northwestern | uso de uma quantidade eficaz de glyx-13, uso de glyx-13 e um antagonista de nmdar e composição farmaceuticamente aceitável compreendendo os mesmos |
| US9987242B2 (en) | 2015-05-05 | 2018-06-05 | Northwestern University | Treatment of Levodopa-induced Dyskinesias |
| CR20210545A (es) * | 2019-05-01 | 2021-12-23 | Boehringer Ingelheim Int | Formas sólidas de un inhibidor de glyt1 |
| CA3188340A1 (en) | 2020-08-13 | 2022-02-17 | Boehringer Ingelheim International Gmbh | Treatment of cognitive impairement associated with schizophrenia |
| KR20230088761A (ko) | 2020-10-13 | 2023-06-20 | 베링거 인겔하임 인터내셔날 게엠베하 | 재가공하는 방법 |
| JP2025528779A (ja) | 2022-08-09 | 2025-09-02 | シーザン ハイスーク ファーマシューティカル カンパニー リミテッド | Ｐｄｅ４ｂ阻害剤及びその用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5981168A (en) * | 1998-05-15 | 1999-11-09 | The University Of British Columbia | Method and composition for modulating amyloidosis |
| EA009903B1 (ru) * | 2003-10-14 | 2008-04-28 | Пфайзер Продактс Инк. | Бициклические [3.1.0] производные в качестве ингибиторов переносчиков глицина |
| AU2005317846B2 (en) * | 2004-12-21 | 2011-12-08 | Merck Sharp & Dohme Limited | Piperidine and azetidine derivatives as GlyT1 inhibitors |
| US20080319043A1 (en) * | 2005-05-03 | 2008-12-25 | Mohammad Salman | 3,6-Disubstituted Azabicyclo (3.1.0) Hexane Derivatives as Muscarinic Receptor Antagonists |
| GB0523998D0 (en) * | 2005-11-25 | 2006-01-04 | Merck Sharp & Dohme | Therapeutic agents |
| CL2007002809A1 (es) * | 2006-09-29 | 2008-04-18 | Actelion Pharmaceuticals Ltd | Compuestos derivados de 3-aza biciclo [3.1.0]hexano; y su uso en el tratamiento de enfermedades tales como desordenes psicoticos y de ansiedad, desordenes del sueno, uso y abuso de sustancias psicoactivas, demencia y deterioro de funciones cognitivas |
-
2009
- 2009-12-29 EP EP09837121A patent/EP2381941A4/en not_active Withdrawn
- 2009-12-29 US US12/648,972 patent/US8497289B2/en not_active Expired - Fee Related
- 2009-12-29 MX MX2011006845A patent/MX2011006845A/es not_active Application Discontinuation
- 2009-12-29 CA CA2747602A patent/CA2747602A1/en not_active Abandoned
- 2009-12-29 BR BRPI0923878-6A patent/BRPI0923878A2/pt not_active IP Right Cessation
- 2009-12-29 AU AU2009335120A patent/AU2009335120A1/en not_active Abandoned
- 2009-12-29 RU RU2011124709/04A patent/RU2011124709A/ru not_active Application Discontinuation
- 2009-12-29 KR KR1020117016603A patent/KR20110117087A/ko not_active Withdrawn
- 2009-12-29 CN CN2009801530939A patent/CN102271677A/zh active Pending
- 2009-12-29 WO PCT/US2009/069716 patent/WO2010078348A1/en not_active Ceased
- 2009-12-29 JP JP2011543717A patent/JP2012514006A/ja active Pending
-
2011
- 2011-06-14 IL IL213541A patent/IL213541A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6876675B2 (ja) | ムスカリンアゴニスト | |
| JP2017535586A5 (enExample) | ||
| JP2010529135A5 (enExample) | ||
| RU2018130727A (ru) | Органические соединения | |
| JP2010538001A5 (enExample) | ||
| BR112012014807A2 (pt) | "compostos adequados para o tratamento de sinucleopatias" | |
| Mazurov et al. | Discovery of 3-(5-chloro-2-furoyl)-3, 7-diazabicyclo [3.3. 0] octane (TC-6683, AZD1446), a novel highly selective α4β2 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders | |
| TW200719886A (en) | Dihydrobenzofuran derivatives and uses thereof | |
| JPWO2015163447A1 (ja) | ４環性化合物の新規結晶 | |
| RU2011124709A (ru) | ДВУЯДЕРНЫЕ ИНГИБИТОРЫ GlyT1 И СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ | |
| EA201590228A1 (ru) | Антагонисты 5-ht3 рецептора | |
| UA114405C2 (uk) | Феніл-3-азабіцикло[3.1.0]гекс-3-илметанони та їх застосування як лікарського засобу | |
| JP2007500168A5 (enExample) | ||
| EA200970760A1 (ru) | Быстро диссоциирующие антагонисты рецептора 2 дофамина | |
| AR058151A1 (es) | Compuestos antagosnistas de los receptores 2 de dopamina de rapida disociacion | |
| MX2009011415A (es) | Derivados de 4-alcoxipiridazina como antagonistas del receptor de dopamina 2 de rapida disociacion. | |
| JP2013537240A5 (enExample) | ||
| EA201291327A1 (ru) | Замещенные 6-метилникотинамиды как позитивные аллостерические модуляторы mglur5 | |
| MX2013001965A (es) | Compuestos disustituidos de tetrahidrofuranilo como antagonistas de receptor de bradiquinina b1 | |
| EA200970553A1 (ru) | Пиперидиниламинопиридазины и их применение в качестве быстро диссоциирующих антагонистов рецептора допамина 2 | |
| MD4345B1 (ro) | Procedeu de sinteză şi forme cristaline ale hidroclorurii de 4-{3-¢cis-hexahidrociclopenta¢c]pirol-2(1H)-il]propoxi}benzamidă şi a bazei libere, compoziţii farmaceutice care le conţin pentru tratamentul tulburărilor cognitive şi psiho-comportamentale | |
| KR20110095400A (ko) | 아자비사이클로－트리플루오로메틸 벤즈아미드 유도체의 신규한 다형태 | |
| BR112014016218A2 (pt) | produto de reação, composição de reação e método para manufaturar uma amina polifuncional | |
| MX2012005597A (es) | Formas cristalinas de pirazolopirimidinas sustituidas. | |
| JP6491213B2 (ja) | 疼痛および他の障害の治療のためのガンマ−アミノ酪酸（ｇａｂａ）類似体 |